How do members experience IPF Phase III Nintedanib (BIBF1120)?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Idiopathic pulmonary fibrosis 4 7

Common side effects

Side effect Patients Percentage
Decreased appetite 2
Abdominal pain 1
Constipation 1
Diarrhea 1
Indigestion 1
Metallic taste in mouth 1

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 2
Mild 3
None 2